Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

Coronavirus (COVID-19) Update: October 30, 2020
Fri, 30 Oct 2020 18:58:56 EDT

  Coronavirus (COVID-19) Update

FDA, Homeland Security Agencies Take Additional Action to Prevent Import of Illegal and Harmful Medical Products Through International Mail Facilities
Fri, 30 Oct 2020 16:54:46 EDT

  Leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection (CBP), and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations (ICE-HSI) signed a Memorandum of Understanding (MOU) to stop harmful products that pose a threat to public health an

FDA Publishes List of Essential Medicines, Medical Countermeasures, Critical Inputs Required by Executive Order
Fri, 30 Oct 2020 09:01:32 EDT

  A recent executive order directed FDA, in consultation with federal partners, to identify a list of essential medicines, medical countermeasures and critical inputs that are medically necessary to have available at all times in an amount adequate to serve patient needs.

Coronavirus (COVID-19) Update: October 28, 2020
Wed, 28 Oct 2020 17:52:10 EDT

  Coronavirus (COVID-19) Update

FDA Approves Lotion for Nonprescription Use to Treat Head Lice
Tue, 27 Oct 2020 15:18:17 EDT

  The FDA has approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch.

Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020
Mon, 26 Oct 2020 16:40:07 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Fri, 23 Oct 2020 17:23:45 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

FDA Approves First Treatment for COVID-19
Thu, 22 Oct 2020 16:54:31 EDT

  FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first treatment for COVID-19 to receive FDA approval.

Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020
Tue, 20 Oct 2020 17:35:57 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: Daily Roundup October 19, 2020
Mon, 19 Oct 2020 17:06:13 EDT

  Coronavirus (COVID-19) Update: Daily Roundup of FDA Actions, October 19, 2020

Coronavirus (COVID-19) Update: Daily Roundup October 15, 2020
Thu, 15 Oct 2020 17:25:29 EDT

  The FDA re-issues Emergency Use Authorization for certain filtering facepiece respirators.

FDA Reissues Emergency Use Authorization for Certain Non-NIOSH-Approved Filtering Face-Piece Respirators Manufactured in China
Thu, 15 Oct 2020 16:56:31 EDT

  The FDA reissued the Emergency Use Authorization (EUA) for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH).

FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications
Thu, 15 Oct 2020 15:00:49 EDT

  Today, FDA issued a Drug Safety Communication announcing label changes that limit the use of pain-relieving and fever-reducing nonsteroidal anti-inflammatory drugs (NSAIDs) after around 20 weeks gestation or later in pregnancy.

FDA Approves First Treatment for Ebola Virus
Wed, 14 Oct 2020 16:35:15 EDT

  Today, the FDA approved Inmazeb, a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

Coronavirus (COVID-19) Update: Daily Roundup October 13, 2020
Tue, 13 Oct 2020 16:53:55 EDT

  The FDA issues and implements new guidance regarding molecular influenza and RSV tests.

FDA Warns Dietary Supplement Companies Illegally Selling Products Containing Cesium Chloride
Tue, 13 Oct 2020 16:17:02 EDT

  FDA has posted five warning letters issued to companies marketing dietary supplements containing cesium chloride. FDA will continue to take action against dietary supplements that contain cesium chloride because of significant safety concerns.

Coronavirus (COVID-19) Update: Daily Roundup October 9, 2020
Fri, 09 Oct 2020 16:42:19 EDT

  The FDA and the Federal Trade Commission issue warning letters for selling fraudulent COVID-19-related products.

Coronavirus (COVID-19) Update: Daily Roundup October 8, 2020
Thu, 08 Oct 2020 16:26:25 EDT

  The FDA updates dashboard on the Coronavirus Treatment Acceleration Program (CTAP) webpage.

FDA awards six grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
Thu, 08 Oct 2020 11:20:09 EDT

  FDA announced awards for six new clinical trial research grants totaling over $16 million over the next four years. The grants, awarded through the Congressionally-funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases.

FDA Reaffirms Commitment to Safety, Security of its Public Health Laboratories
Thu, 08 Oct 2020 10:49:28 EDT

  FDA’s mission to protect and promote public health has always relied on a rigorous analysis of the scientific data available and we’re dedicated to ensuring our staff’s safety by continuing to strengthen a culture that prioritizes workplace safety.

Food and Drugs Administration--Recalls/Safety Alerts

Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of all Sigma Spectrum Infusion Pumps (V6, V8 and IQ)
Wed, 28 Oct 2020 10:19:00 EDT

  Baxter International Inc. announced today it has issued an Urgent Device Correction to reinforce important safety information regarding cleaning practices of all Spectrum infusion pumps distributed in the United States, Canada, and the Caribbean, as deviations from the specified cleaning methods may

Allergy Alert Issued for Undeclared Egg in Prepared Macaroni & Cheese Sold at Whole Foods Market Stores in Five States
Wed, 28 Oct 2020 00:00:00 EDT

  Whole Foods Market is voluntarily recalling select prepared Macaroni & Cheese products from stores across five states because they contain undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these produ

Homestead Creamery Issues Voluntary Glass Bottled Product Recall
Wed, 28 Oct 2020 00:00:00 EDT

  Homestead Creamery of Wirtz, VA is voluntarily recalling glass bottled products because of a suspected issue with the bottle sanitizing process. Glass bottled product in question may have a strong sanitizer odor which may affect the taste and quality of the product. There is no known health risk ass

Russ Davis Wholesale Issues Allergy Alert on Undeclared Egg in Mixed Veggie Cup With Dip
Wed, 28 Oct 2020 00:00:00 EDT

  Russ Davis Wholesale of Wadena, Minnesota is recalling individual serving cups of Mixed Veggie Cup with Dip because it may contain undeclared Egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
Tue, 27 Oct 2020 00:00:00 EDT

  Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level. This product may be contaminated with
the bacteria Burkholderia lata.


Allergy Alert Issued By Incredible Fish, Inc. for Undeclared Milk, Fish and Eggs in Incredible Stone Crab Mustard Sauce
Sat, 24 Oct 2020 00:00:00 EDT

  Incredible Fish, Inc. is voluntarily recalling a small quantity of Incredible Stone Crab Mustard Sauce because its labeling inadvertently did not identify the following allergens in the product: milk, fish, and eggs. People who have an allergy or severe sensitivity to milk, fish, or eggs run the ri

Orca Bay Foods, LLC Issues Allergy Alert on Undeclared Wheat and Milk Allergens in Gluten Free Battered Halibut
Fri, 23 Oct 2020 19:09:00 EDT

  Orca Bay Foods of Seattle, WA is recalling 4,450 lb. (356 cases) of 10 oz. retail box Trader Joe's brand Gluten Free Battered Halibut SKU 00503822, because it contains undeclared wheat and milk allergens.

Comercial Mexicana International Inc. Recalls “Tropique Assorted Fruit Jelly Bag 30/9PCS/10.06oz and Tropique Jelly Animal Jar 6/26oz ” Due to Possible Health Risk
Thu, 22 Oct 2020 14:10:00 EDT

  COMERCIAL MEXICANA INTERNATIONAL INC in Bethpage New York is recalling the product because it may pose a choking hazard. Small jelly cups containing seaweed extract (carrageenan) has been identified as a potential choking hazard in children

Hadson Toko Trading Co., Inc. Recalls Eishindo Mini Cup Jelly (50pcs) Because of Potential Choking Hazard
Wed, 14 Oct 2020 00:00:00 EDT

  HADSON (TOKO) TRADING CO., INC. OF MASPETH, NY is recalling its 28.2oz (800g) bags of EISHINDO MINI CUP JELLY (50 pcs) (迷你果凍杯(大)) due to the product being a potential choking hazard based off of its product size and consistency. Small jelly cups have previously been implicated in choking deaths of c

Red Monkey Foods, Inc. Recalls Parsley and Herbes De Provence Because of Possible Health Risk
Tue, 13 Oct 2020 00:00:00 EDT

  Red Monkey Foods, Inc. out of an abundance of caution is voluntarily recalling select organic parsley as part of a recall initiated by High Quality Organics (HQO). HQO has issued a recall for a lot of parsley because a sample was tested by one of HQO’s customers and was found to be potentially conta

Sauer Brands, Inc. Voluntarily Recalls Certain The Spice Hunter Products Because of Potential Salmonella Contamination
Mon, 12 Oct 2020 00:00:00 EDT

  Sauer Brands, Inc. is voluntarily recalling The Spice Hunter Products listed below due to the potential presence of Salmonella. After initially certifying that our raw material had tested negative for salmonella, and was fit for human consumption, our supplier notified us of the potential presence o

B&G Foods Issues Voluntary Allergy Alert for a Limited Number of Boxes of Back to Nature® Organic Rosemary & Olive Oil Stoneground Wheat Crackers Containing Peanut Butter Cookies
Fri, 09 Oct 2020 00:00:00 EDT

  B&G Foods announced today it is voluntarily recalling a very limited number of boxes of a single date code of 6 oz. Back to Nature Organic Rosemary & Olive Oil Stoneground Wheat Crackers,

Sunshine Mills, Inc. Expands Previously Announced Voluntary Recall of Certain Pet Food Products Due to Potentially Elevated Levels of Aflatoxin
Thu, 08 Oct 2020 00:00:00 EDT

  Sunshine Mills, Inc. is expanding its voluntary recall of certain pet food products that were made with corn that contained Aflatoxin at levels above FDA’s action levels.

Meijer Recalls Whole Cantaloupes and Select Cut Cantaloupe Trays Due to Potential Health Risk
Wed, 07 Oct 2020 11:35:00 EDT

  Meijer, in conjunction with Eagle Produce, LLC in Aguila, AZ., is announcing a voluntary recall of whole cantaloupe and select cut cantaloupe fruit trays and bowls. The recall is part of a sampling investigation by the Michigan Department of Agriculture and Rural Development and is due to the potent

Country Fresh Expands Voluntary Recall
Sat, 03 Oct 2020 00:00:00 EDT

  Country Fresh is extending their voluntary recall issued on October 2, 2020 to include various containers of “Freshness Guaranteed “cut and/or sliced apples, grapes, mangos, pineapples and cantaloupe distributed by Walmart. The recall is a precautionary measure due to a possible health risk from L

Seneca Recalls Cinnamon Apple Chips Because of Possible Health Risk
Fri, 02 Oct 2020 00:00:00 EDT

  Seneca Snack Company, a Washington Corporation, is announcing a voluntary recall of Seneca Cinnamon Apple Chips and Clancy’s Cinnamon Apple Chips due to possible Salmonella contamination.

Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Fri, 02 Oct 2020 00:00:00 EDT

  Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, & 750mg to the consumer level. Marksans performed N-Nitrosodimethylamine (NDMA) testing of

Ashtel Studios Issues Voluntary Recall of Licensed Hand Sanitizers Packaged in 0.84 Fluid Ounce Pouches Due to Misbranding Because They Resemble Food and Drink Container Pouches
Thu, 01 Oct 2020 15:00:00 EDT

  Ashtel Studios has announced a voluntary recall of all lots of licensed hand sanitizer packaged in .84 oz containers resembling food and drink pouches labeled with various children’s characters listed in the table below to the consumer level. The products are being recalled because they are packaged

Country Fresh Voluntary Product Recall
Thu, 01 Oct 2020 00:00:00 EDT

  Country Fresh is initiating a voluntary recall of a limited quantity of watermelon chunks from select stores as a precautionary measure due to a possible health risk from Listeria monocytogenes detected on equipment used in packing this product.
FDA made these findings during a recent inspection.


Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Wed, 23 Sep 2020 12:16:00 EDT

  Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to

What's New: Drugs RSS Feed

PDUFA VII: Fiscal Years 2023 – 2027
Fri, 30 Oct 2020 17:30:11 EDT

  Prescription Drug User Fee Act (PDUFA) that provides FDA with the necessary resources to maintain a predictable and efficient review process for human drug and biologic products.

FDA, Homeland Security Agencies Take Additional Action to Prevent Import of Illegal and Harmful Medical Products Through International Mail Facilities
Fri, 30 Oct 2020 16:54:46 EDT

  Leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection (CBP), and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations (ICE-HSI) signed a Memorandum of Understanding (MOU) to stop harmful products that pose a threat to public health an

User Fee Lists
Fri, 30 Oct 2020 16:32:58 EDT

  Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

Generic Drug Facilities, Sites and Organization Lists
Fri, 30 Oct 2020 16:10:29 EDT

  Generic Drug Facilities, Sites and Organization Lists

Consumer Updates
Fri, 30 Oct 2020 15:48:16 EDT

  Science-based health and safety information you can trust.

FDA updates on hand sanitizers consumers should not use
Fri, 30 Oct 2020 15:33:48 EDT

  FDA Warns consumers and healthcare professionals of Hand Sanitizers contaminated with Methanol

Antimicrobial Resistance Information from FDA
Fri, 30 Oct 2020 15:15:31 EDT

  Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

Compounding Information for States
Fri, 30 Oct 2020 14:32:59 EDT

  FDA collaborates with state officials in a variety of ways, including by sharing information about compounders who engage in poor practices that could put patients at risk, sharing information about complaints and adverse events, and sharing findings from inspections.

What's New Related to Drugs
Fri, 30 Oct 2020 14:31:15 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Dermatologic and Ophthalmic Drugs Advisory Committee Roster
Fri, 30 Oct 2020 14:06:39 EDT

  This page contains the DODAC roster, which lists the current members and the current number of vacancies for the committee.

FDA Patient Engagement Partnerships
Fri, 30 Oct 2020 12:26:43 EDT

  FDA Patient Engagement Partnerships

2020 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee
Fri, 30 Oct 2020 11:52:10 EDT

  2020 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee

December 16, 2020 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement - 12/16/2020 - 12/16/2020
Fri, 30 Oct 2020 11:47:52 EDT

  December 16, 2020 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement

Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling - 01/26/2021 - 01/26/2021
Fri, 30 Oct 2020 10:42:20 EDT

  The FDA is hosting a workshop to communicate regulatory concerns and considerations with using non-clinical assays for comparative immunogenicity risk assessment. In addition, this workshop seeks to generate discussions on the following four sessions/topics: In silico methods to assess binding affinity to MHC.

Executive Order 13944 List of Essential Medicines, Medical Countermeasures, and Critical Inputs
Fri, 30 Oct 2020 08:51:52 EDT

  In consultation with other federal partners, FDA has developed a list of drug and biological product essential medicines, drug, biological product, and device medical countermeasures, and critical inputs, as required by Executive Order 13944. FDA welcomes public comment on this list.

FDA Adverse Event Reporting System (FAERS) Public Dashboard
Thu, 29 Oct 2020 16:08:13 EDT

  Four FAERS summary statistics reports updated with data through December 31, 2013.

Competitive Generic Therapy Approvals
Thu, 29 Oct 2020 14:19:34 EDT

  A list of all FDA-approved abbreviated new drug applications for drug products that received a Competitive Generic Therapy designation under section 506H of the Federal Food, Drug, and Cosmetic Act.

November 2, 2020 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement - 11/02/2020 - 11/02/2020
Thu, 29 Oct 2020 13:06:24 EDT

  November 2, 2020 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement

2018 Meeting Materials, Peripheral and Central Nervous System Drugs Advisory Committee
Thu, 29 Oct 2020 11:31:55 EDT

  This page contains the meeting materials for the Peripheral and Central Nervous System Drugs Advisory Committee meetings for 2018, including the meeting announcement, briefing materials, committee roster, webcast information, agenda, committee questions, meeting roster, presentation slides, summary minutes, and transcript.

2016 Meeting Materials, Peripheral and Central Nervous System Drugs Advisory Committee
Thu, 29 Oct 2020 11:28:33 EDT

  This page contains the meeting materials for the Peripheral and Central Nervous Advisory Committee meetings for 2016, including the meeting announcement, briefing materials, committee roster, webcast information, agenda, committee questions, meeting roster, presentation slides, summary minutes, etc.

Whats New Vaccines Blood Biologics RSS Feed

COVID-19 Vaccines
Fri, 30 Oct 2020 16:34:11 EDT

  FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

Consumer Updates
Fri, 30 Oct 2020 15:48:16 EDT

  Science-based health and safety information you can trust.

Antimicrobial Resistance Information from FDA
Fri, 30 Oct 2020 15:15:31 EDT

  Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - 10/22/2020 - 10/22/2020
Fri, 30 Oct 2020 13:30:47 EDT

  This is the CBER Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement.

FDA Patient Engagement Partnerships
Fri, 30 Oct 2020 12:26:43 EDT

  FDA Patient Engagement Partnerships

What’s New for Biologics
Fri, 30 Oct 2020 11:58:03 EDT

  Latest news from the Center for Biologics Evaluation and Research

General Biologics, Notices, Proposed and Final Rules
Fri, 30 Oct 2020 11:26:14 EDT

  General Biologics, Notices, Proposed and Final Rules

Executive Order 13944 List of Essential Medicines, Medical Countermeasures, and Critical Inputs
Fri, 30 Oct 2020 08:51:52 EDT

  In consultation with other federal partners, FDA has developed a list of drug and biological product essential medicines, drug, biological product, and device medical countermeasures, and critical inputs, as required by Executive Order 13944. FDA welcomes public comment on this list.

Section 8400: Marketing Applications
Thu, 29 Oct 2020 16:28:21 EDT

  This is the SOPP Section 8400: Marketing Applications main page.

VAXELIS
Thu, 29 Oct 2020 15:14:03 EDT

  VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae (H. influenzae) type b. VAXELIS is approved for use as a 3 dose series in children 6 weeks through 4 years of age (prior t

CBER Biologics Effectiveness and Safety (BEST) System
Thu, 29 Oct 2020 13:04:13 EDT

  This is the main page for CBER's Biologics Effectiveness and Safety (BEST) System.

Roster of the Allergenic Products Advisory Committee
Thu, 29 Oct 2020 13:04:07 EDT

  As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Roster of the Vaccines and Related Biological Products Advisory Committee
Thu, 29 Oct 2020 13:04:03 EDT

  This is the Roster of the Vaccines and Related Biological Products Advisory Committee

Influenza neuraminidase antigenicity and efficacy in vaccines
Wed, 28 Oct 2020 10:27:03 EDT

  Robert Daniels' research project "Influenza neuraminidase antigenicity and efficacy in vaccines".

Immunogenicity of Gene Therapy Products
Tue, 27 Oct 2020 16:55:42 EDT

  Ronit Mazor's research project "Immunogenicity of Gene Therapy Products".

Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2020
Tue, 27 Oct 2020 16:41:24 EDT

  This is the list of guidance topics CBER is considering for development during Calendar Year 2020.

Biologics Guidances
Tue, 27 Oct 2020 15:25:56 EDT

  This page displays links to Biologics Guidance documents.

Regenerative Medicine Advanced Therapy Designation
Tue, 27 Oct 2020 14:38:21 EDT

  Eligibility requirements for a regenerative medicine advanced therapy (RMAT) designation. Information on when and where to submit the request is also provided.

Gastrointestinal Viruses: Understanding Diversity and Immune Responses to Inform Vaccine Design
Tue, 27 Oct 2020 13:23:32 EDT

  Gabriel Parra's research project "Gastrointestinal Viruses: Understanding Diversity and Immune Responses to Inform Vaccine Design".

Vaccines Research
Tue, 27 Oct 2020 11:29:16 EDT

  List of Vaccines Research.







 
 

Contact Us


Corporate Headquarters


Practical Compliance Solutions
One Orient Way - Suite F156
Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2020 - Copyright Practical Compliance Solutions - All rights reserved